• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

heart failure

Hypertension.
Posted inCardiology, Clinical Trials, In the Pipeline

Hypertension Treatment With One Shot Every Six Months

by Julia Mardi and Timur Burkhanayev April 27, 2024May 8, 2024

Zilebesiran and tonlamarsen are advanced and convenient ways to treat high blood pressure.

heart
Posted inCardiology, Metabolism, New Drugs, Regulatory

Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy

by Mark Gubar April 29, 2022April 5, 2024

Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.

Posted inMetabolism, New Drugs, Regulatory

Kerendia: New Drug for Diabetic Kidney Disease

by Mark Gubar February 16, 2022September 8, 2022

Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.

Posted inCardiology, Metabolism, New Drugs, Rare/Orphan Diseases, Regulatory

Leqvio: Newest Drug Against ‘Very Bad’ Cholesterol

by Mark Gubar December 23, 2021April 5, 2024

Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.

obesity
Posted inMetabolism, New Drugs, Regulatory

Wegovy: Most Effective Drug for Weight Loss

by Nik Resovski and Timur Burkhanayev June 9, 2021September 8, 2022

Semaglutide can help you lose 15% of your excess weight in a year. And even more.

BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×